Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. L59d69szn5
2. Rac-(ru(dmb)2(ip-3t))cl2
3. Tld1433
4. Tld-1433
5. 1471479-22-7
6. Unii-l59d69szn5
7. Ruthenium(2+), Bis(4,4'-dimethyl-2,2'-bipyridine-.kappa.n1,.kappa.n1')(2-(2,2':5',2''-terthiophen)-5-yl-1h-imidazo(4,5-f)(1,10)phenanthroline-.kappa.n7,.kappa.n8)-, Chloride (1:2), (oc-6-21)-
8. Ruthenium(2+), Bis(4,4'-dimethyl-2,2'-bipyridine-kappan1,kappan1')(2-(2,2':5',2''-terthiophen)-5-yl-1h-imidazo(4,5-f)(1,10)phenanthroline-kappan7,kappan8)-, Chloride (1:2), (oc-6-21)-
| Molecular Weight | 1007.1 g/mol |
|---|---|
| Molecular Formula | C49H38Cl2N8RuS3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 5 |
| Exact Mass | 1006.080202 g/mol |
| Monoisotopic Mass | 1006.080202 g/mol |
| Topological Polar Surface Area | 191 Ų |
| Heavy Atom Count | 63 |
| Formal Charge | 0 |
| Complexity | 843 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 6 |
ABOUT THIS PAGE
A TLD-1433 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of TLD-1433, including repackagers and relabelers. The FDA regulates TLD-1433 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. TLD-1433 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A TLD-1433 supplier is an individual or a company that provides TLD-1433 active pharmaceutical ingredient (API) or TLD-1433 finished formulations upon request. The TLD-1433 suppliers may include TLD-1433 API manufacturers, exporters, distributors and traders.
TLD-1433 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of TLD-1433 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right TLD-1433 GMP manufacturer or TLD-1433 GMP API supplier for your needs.
A TLD-1433 CoA (Certificate of Analysis) is a formal document that attests to TLD-1433's compliance with TLD-1433 specifications and serves as a tool for batch-level quality control.
TLD-1433 CoA mostly includes findings from lab analyses of a specific batch. For each TLD-1433 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
TLD-1433 may be tested according to a variety of international standards, such as European Pharmacopoeia (TLD-1433 EP), TLD-1433 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (TLD-1433 USP).
LOOKING FOR A SUPPLIER?
